BIO-key adjourns annual shareholder meeting to Oct. 2 after insufficient votes on warrant proposal
BKYI•Meeting adjourned after proposal 4 lacked enough votes
BIO-key delayed its 2026 annual shareholder meeting due to insufficient votes to pass Proposal 4.
Proposal 4 seeks Nasdaq rule approval for issuing up to 1,236,668 common shares from warrants tied to an Aug. 10, 2026 inducement.
The meeting will reconvene Oct. 2, 2026 at 10:00 a.m. at its Holmdel, New Jersey offices; polls remain open.
The record date stays July 15, 2026; shareholders who have not voted on Proposal 4 must submit a new proxy.
